Literature DB >> 19480954

Epidemiology and genotype distribution of human papillomavirus (HPV) in women of Sardinia (Italy).

Giuseppina Masia1, Anna Paola Mazzoleni, Graziella Contu, Sergio Laconi, Luigi Minerba, Stefania Montixi, Francesca Montis, Annamaria Onano, Emanuela Porcedda, Rosa Cristina Coppola.   

Abstract

The human papillomavirus (HPV) infection is necessary for the development of cervical cancer. Our study aims to evaluate the rate of HPV circulation in our population, to identify the prevalent genotypes and to establish correlation with cervical abnormalities. Furthermore, the awareness of women about HPV issues was investigated. This study included 864 women attending the Oncologic Prevention Service for their routine Pap test screening or the Health Promotion Mother-Child Service for counselling about sexual activity, from July 2006 to September 2007. All the participants gave their informed consent to be enrolled in the study and were invited to fill in a questionnaire about the socio-cultural state, sexual activity and awareness about HPV. The women samples were tested for HPV-DNA and HPV genotypes: any type of HPV-DNA was detected in 31.0% of the women; single or multiple infections sustained by HPV-16 or HPV-18 represented 43.5% of all HPV infections, accounting for infections in 11.8% of the recruited women. The HPV and high-risk HPV (HR-HPV) prevalence significantly declined in women older than 46 years. The Pap test result was available in 490 women; 48.1% of the Pap test positive women had also an HPV infection and among these 22.7% were infected by HPV-16 and/or HPV-18 genotype, while 51.9% (94/181) were HPV negative. The analysis by binary logistic regression showed that genotype 16 and/or 18 is a risk factor for the Pap positive test with a odds ratio (OR) of 2.9 (95% C.I. 1.4-5.9) and 3.6 (95% C.I. 1.58-8.42) respectively, while age is a protective factor (OR 0.97, C.I. 95% 0.96-0.99); furthermore, the mean age at the first sexual intercourse and the mean number of partners since the beginning of sexual activity, were statistically associated with the risk of HPV infection. More than half of women were aware about HPV, its sexual transmission and of its correlation with cervix cancer. Our findings evidenced that HPV infection is frequent in women aged 18-46 years in Sardinia and particularly that 16 and 18 HPV genotypes are detectable in more than 40% of the infected women. The proportion of women informed about HPV issues is sufficient to guarantee an aware approach to HPV vaccination.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19480954     DOI: 10.1016/j.vaccine.2008.10.095

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  Burden of Disease of Human Papillomavirus (HPV): Hospitalizations in the Marche and Veneto Regions. An observational study.

Authors:  Francesco Saverio Mennini; Gianluca Fabiano; Andrea Marcellusi; Paolo Sciattella; Mario Saia; Silvia Cocchio; Vincenzo Baldo
Journal:  Clin Drug Investig       Date:  2018-02       Impact factor: 2.859

2.  Prevalence of HPV high and low risk types in cervical samples from the Italian general population: a population based study.

Authors:  Paolo Giorgi Rossi; Simonetta Bisanzi; Irene Paganini; Angela Di Iasi; Claudio Angeloni; Aurora Scalisi; Rosalba Macis; Maria Teresa Pini; Francesco Chini; Francesca Maria Carozzi
Journal:  BMC Infect Dis       Date:  2010-07-20       Impact factor: 3.090

3.  Prevalence and molecular epidemiology of human papillomavirus infection in italian women with cervical cytological abnormalities.

Authors:  Angelo Meloni; Roberta Pilia; Marcello Campagna; Antonella Usai; Giuseppina Masia; Valeria Caredda; Rosa Cristina Coppola
Journal:  J Public Health Res       Date:  2014-03-26

4.  A cross-sectional study to estimate high-risk human papillomavirus prevalence and type distribution in Italian women aged 18-26 years.

Authors:  Cristina Giambi; Serena Donati; Francesca Carozzi; Stefania Salmaso; Silvia Declich; Marta L Ciofi degli Atti; Guglielmo Ronco; Maria P Alibrandi; Silvia Brezzi; Natalina Collina; Daniela Franchi; Amedeo Lattanzi; Maria C Minna; Roberto Nannini; Elena Barretta; Elena Burroni; Anna Gillio-Tos; Vincenzo Macallini; Paola Pierotti; Antonino Bella
Journal:  BMC Infect Dis       Date:  2013-02-07       Impact factor: 3.090

5.  Prevalence and type distribution of human papillomavirus infection in women from North Sardinia, Italy.

Authors:  Andrea Piana; Giovanni Sotgiu; Paolo Castiglia; Stefania Pischedda; Clementina Cocuzza; Giampiero Capobianco; Vincenzo Marras; Salvatore Dessole; Elena Muresu
Journal:  BMC Public Health       Date:  2011-10-11       Impact factor: 3.295

6.  Prevalence of human papillomavirus in young Italian women with normal cytology: how should we adapt the national vaccination policy?

Authors:  Donatella Panatto; Daniela Amicizia; Elisabetta Tanzi; Silvia Bianchi; Elena Rosanna Frati; Carla Maria Zotti; Piero Luigi Lai; Angela Bechini; Stefania Rossi; Roberto Gasparini
Journal:  BMC Infect Dis       Date:  2013-12-06       Impact factor: 3.090

7.  High HPV-51 prevalence in invasive cervical cancers: results of a pre-immunization survey in North Sardinia, Italy.

Authors:  Andrea Piana; Giovanni Sotgiu; Clementina Cocuzza; Rosario Musumeci; Vincenzo Marras; Stefania Pischedda; Silvia Deidda; Elena Muresu; Paolo Castiglia
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

8.  Monitoring vaccine and non-vaccine HPV type prevalence in the post-vaccination era in women living in the Basilicata region, Italy.

Authors:  Francesca Carozzi; Donella Puliti; Cristina Ocello; Pasquale Silvio Anastasio; Espedito Antonio Moliterni; Emilia Perinetti; Laurence Serradell; Elena Burroni; Massimo Confortini; Paola Mantellini; Marco Zappa; Géraldine Dominiak-Felden
Journal:  BMC Infect Dis       Date:  2018-01-15       Impact factor: 3.090

9.  Prevalence of human papillomavirus infection and genotyping for population-based cervical screening in developed regions in China.

Authors:  Yanru Zhang; Yueyun Wang; Li Liu; Chun Guo; Zhihua Liu; Shaofa Nie
Journal:  Oncotarget       Date:  2016-09-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.